tradingkey.logo
tradingkey.logo
Suchen

Labcorp Holdings Inc

LH
Zur Watchlist hinzufügen
321.480USD
-3.380-1.04%
Trading geöffnet 09/09, 09:40ET
26.01BMarktkapitalisierung
28.29KGV TTM

mehr Informationen über Labcorp Holdings Inc Unternehmen

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Labcorp Holdings Inc Profil

BörsenkürzelLH
Name des UnternehmensLabcorp Holdings Inc
IPO-datumApr 24, 1991
CEOSchechter (Adam H)
Anzahl der mitarbeiter70000
WertpapierartOrdinary Share
GeschäftsjahresendeApr 24
Addresse358 S Main St
StadtBURLINGTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl27215
Telefon13362291127
Websitehttps://www.labcorp.com/
BörsenkürzelLH
IPO-datumApr 24, 1991
CEOSchechter (Adam H)

Führungskräfte von Labcorp Holdings Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
102.56K
-4.55%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
13.74K
--
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
6.96K
-13.29%
Ms. Kerrii B. Anderson
Ms. Kerrii B. Anderson
Independent Director
Independent Director
6.85K
-43.79%
Mr. Bryan T. Vaughn
Mr. Bryan T. Vaughn
Executive Vice President - Diagnostics
Executive Vice President - Diagnostics
6.75K
--
Ms. Sandra Dillard van Der Vaart
Ms. Sandra Dillard van Der Vaart
Executive Vice President, Chief Legal Officer, and Corporate Secretary
Executive Vice President, Chief Legal Officer, and Corporate Secretary
5.82K
+62.94%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
102.56K
-4.55%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
13.74K
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Labcorp Holdings Inc?

Die fünf größten Anteilseigner von Labcorp Holdings Inc sind: Mr. Adam H. Schechter

Wie viele Institutionen halten Anteile an Labcorp Holdings Inc (LH)?

Mit Stand vom 2026Q1 halten 1855 Institutionen Anteile an Labcorp Holdings Inc, mit einem Gesamtmarktwert von etwa 88.74M, was 108.22% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 5570263.00 gestiegen.
tradingkey.logo
Risikohinweis: Unsere Website und mobile App bieten lediglich allgemeine Informationen zu bestimmten Anlageprodukten. Finsights stellt keine Finanzberatung oder Empfehlung für ein Anlageprodukt bereit, und die Bereitstellung solcher Informationen darf nicht als Finanzberatung durch Finsights ausgelegt werden.
Anlageprodukte unterliegen erheblichen Anlagerisiken, einschließlich des möglichen Verlusts des investierten Kapitals und sind möglicherweise nicht für jeden geeignet. Die vergangene Wertentwicklung von Anlageprodukten ist nicht unbedingt ein Hinweis auf deren zukünftige Wertentwicklung.
Finsights kann Drittanbietern oder Partnern erlauben, Werbung auf unserer Website oder in unserer mobilen App oder in Teilen davon zu platzieren oder bereitzustellen. Finsights kann für diese Anzeigenvergütung erhalten, basierend auf Ihrer Interaktion mit den Werbeanzeigen.
© Urheberrecht: FINSIGHTS MEDIA PTE. LTD. Alle Rechte vorbehalten.